Emerging leadership lecture: Inflammatory bowel disease in Asia: Emergence of a "Western" disease

Journal of Gastroenterology and Hepatology (Australia)

Volumn 30, Issue 3, 2015, Pages 440-445

  Ng, Siew C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Epidemiology; Genetics; IBD; Risk factors

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; TUMOR NECROSIS FACTOR; DIGITOXIGENIN; INCICH-D7; NOD2 PROTEIN, HUMAN; TNFSF15 PROTEIN, HUMAN; VASCULAR ENDOTHELIAL GROWTH INHIBITOR;

ASIA; AUTOPHAGY; BREAST FEEDING; CROHN DISEASE; ENVIRONMENTAL FACTOR; EVOLUTION; FAMILY HISTORY; HEREDITY; HUMAN; HYGIENE; INCIDENCE; INFLAMMATORY BOWEL DISEASE; PATHOGENESIS; PET ANIMAL; PHENOTYPE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; ULCERATIVE COLITIS; ANALOGS AND DERIVATIVES; CASE CONTROL STUDY; COLITIS, ULCERATIVE; ENVIRONMENT; GENETIC POLYMORPHISM; GENETICS; INFLAMMATORY BOWEL DISEASES; INTESTINE MUCOSA; MICROBIOLOGY;

ASIA; AUTOPHAGY; BREAST FEEDING; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; DIGITOXIGENIN; ENVIRONMENT; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; NOD2 SIGNALING ADAPTOR PROTEIN; PETS; POLYMORPHISM, GENETIC; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 15;

EID: 84923251444     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12859     Document Type: Review

References (45)

1. Lepage P, Leclerc MC, Joossens M etal. A metagenomic insight into our gut's microbiome. Gut 2013; 62: 146-158.
2. Jostins L, Ripke S, Weersma RK etal. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012; 491: 119-124.
3. Molodecky NA, Soon IS, Rabi DM etal. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012; 142: 46-54.
4. Thia KT, Loftus EV, Jr, Sandborn WJ, Yang SK. An update on the epidemiology of inflammatory bowel disease in Asia. Am. J. Gastroenterol. 2008; 103: 3167-3182.
5. Yang SK, Yun S, Kim JH etal. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study. Inflamm. Bowel Dis. 2008; 14: 542-549.
6. Sood A, Midha V, Sood N, Bhatia AS, Avasthi G. Incidence and prevalence of ulcerative colitis in Punjab, North India. Gut 2003; 52: 1587-1590.
7. Zhao J, Ng SC, Lei Y etal. First prospective, population-based inflammatory bowel disease incidence study in mainland of China: the emergence of "western" disease. Inflamm. Bowel Dis. 2013; 19: 1839-1845.
8. Zeng Z, Zhu Z, Yang Y etal. Incidence and clinical characteristics of inflammatory bowel disease in a developed region of Guangdong Province, China: a prospective population-based study. J. Gastroenterol. Hepatol. 2013; 28: 1148-1153.
9. Yang H, Li Y, Wu W etal. The incidence of inflammatory bowel disease in Northern China: a prospective population-based study. PLoS ONE 2014; 9: e101296.
10. Ng SC, Tang W, Ching JY etal. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-Pacific Crohn's and Colitis Epidemiology Study. Gastroenterology 2013; 145: 158-165.
11. Wilson J, Hair C, Knight R etal. High incidence of inflammatory bowel disease in Australia: a prospective population-based Australian incidence study. Inflamm. Bowel Dis. 2010; 16: 1550-1556.
12. Wei SC, Lin MH, Tung CC etal. A nationwide population-based study of the inflammatory bowel diseases between 1998 and 2008 in Taiwan. BMC Gastroenterol. 2013; 13: 166.
13. Asakura K, Nishiwaki Y, Inoue N, Hibi T, Watanabe M, Takebayashi T. Prevalence of ulcerative colitis and Crohn's disease in Japan. J. Gastroenterol. 2009; 44: 659-665.
14. Ng SC. Epidemiology of inflammatory bowel disease: focus on Asia. Best Pract. Res. Clin. Gastroenterol. 2014; 28: 363-372.
15. Prideaux L, Kamm MA, De Cruz PP, Chan FK, Ng SC. Inflammatory bowel disease in Asia: a systematic review. J. Gastroenterol. Hepatol. 2012; 27: 1266-1280.
16. Prideaux L, Kamm MA, De CP etal. Comparison of clinical characteristics and management of inflammatory bowel disease in Hong Kong versus Melbourne. J. Gastroenterol. Hepatol. 2012; 27: 919-927.
17. Hou JK, El-Serag H, Thirumurthi S. Distribution and manifestations of inflammatory bowel disease in Asians, Hispanics, and African Americans: a systematic review. Am. J. Gastroenterol. 2009; 104: 2100-2109.
18. Ouyang Q, Tandon R, Goh KL etal. Management consensus of inflammatory bowel disease for the Asia-Pacific region. J. Gastroenterol. Hepatol. 2006; 21: 1772-1782.
19. Park JB, Yang SK, Byeon JS etal. Familial occurrence of inflammatory bowel disease in Korea. Inflamm. Bowel Dis. 2006; 12: 1146-1151.
20. Ng SC, Tang W, de Silva J. Natural history of inflammatory bowel disease in Asia: a follow-up population-based cohort study. Gastroenterology 2014; (Suppl. 1): 1012.
21. Anderson CA, Boucher G, Lees CW etal. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat. Genet. 2011; 43: 246-252.
22. Asano K, Matsushita T, Umeno J etal. A genome-wide association study identifies three new susceptibility loci for ulcerative colitis in the Japanese population. Nat. Genet. 2009; 41: 1325-1329.
23. Yang SK, Hong M, Zhao W etal. Genome-wide association study of Crohn's disease in Koreans revealed three new susceptibility loci and common attributes of genetic susceptibility across ethnic populations. Gut 2014; 63: 80-87.
24. Ng SC, Tsoi KK, Kamm MA etal. Genetics of inflammatory bowel disease in Asia: systematic review and meta-analysis. Inflamm. Bowel Dis. 2012; 18: 1164-1176.
25. Hugot JP. CARD15/NOD2 mutations in Crohn's disease. Ann. N. Y. Acad. Sci. 2006; 1072: 9-18.
26. Ogura Y, Bonen DK, Inohara N etal. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603-606.
27. Guo QS, Xia B, Jiang Y, Qu Y, Li J. NOD2 3020insC frameshift mutation is not associated with inflammatory bowel disease in Chinese patients of Han nationality. World J. Gastroenterol. 2004; 10: 1069-1071.
28. Croucher PJ, Mascheretti S, Hampe J etal. Haplotype structure and association to Crohn's disease of CARD15 mutations in two ethnically divergent populations. Eur. J. Hum. Genet. 2003; 11: 6-16.
29. Inoue N, Tamura K, Kinouchi Y etal. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 2002; 123: 86-91.
30. Leong RW, Armuzzi A, Ahmad T etal. NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population. Aliment. Pharmacol. Ther. 2003; 17: 1465-1470.
31. Tremelling M, Cummings F, Fisher SA etal. IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease. Gastroenterology 2007; 132: 1657-1664.
32. Van LJ, Russell RK, Nimmo ER etal. IL23R Arg381Gln is associated with childhood onset inflammatory bowel disease in Scotland. Gut 2007; 56: 1173-1174.
33. Yamazaki K, Onouchi Y, Takazoe M, Kubo M, Nakamura Y, Hata A. Association analysis of genetic variants in IL23R, ATG16L1 and 5p13.1 loci with Crohn's disease in Japanese patients. J. Hum. Genet. 2007; 52: 575-583.
34. Yang SK, Park M, Lim J etal. Contribution of IL23R but not ATG16L1 to Crohn's disease susceptibility in Koreans. Inflamm. Bowel Dis. 2009; 15: 1385-1390.
35. Xu S, Zhou F, Tao J etal. Exome sequencing identifies DLG1 as a novel gene for potential susceptibility to Crohn's disease in a Chinese family study. PLoS ONE 2014; 9: e99807.
36. Yang SK, Hong M, Zhao W etal. Genome-wide association study of ulcerative colitis in Koreans suggests extensive overlapping of genetic susceptibility with Caucasians. Inflamm. Bowel Dis. 2013; 19: 954-966.
37. Sommeren SV, International IBD Genetics Consortium. Trans-Ethnic Association Study of IBD identifies 14 new disease loci and demonstrates pervasive sharing of genetic risk factors and phenotypic features between Europeans and non-Europeans. supplement ed. 2014.
38. Ng SC, Bernstein CN, Vatn MH etal. Geographical variability and environmental risk factors in inflammatory bowel disease. Gut 2013; 62: 630-649.
39. Lakatos PL, Vegh Z, Lovasz BD, David G, Pandur T, Erdelyi Z. Is current smoking still an important environmental factor for inflammatory bowel disease? Results from a population-based incident cohort. 2012:in press.
40. Hou JK, Abraham B, El-Serag H. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am. J. Gastroenterol. 2011; 106: 563-573.
41. Sakamoto N, Kono S, Wakai K etal. Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan. Inflamm. Bowel Dis. 2005; 11: 154-163.
42. Ng SC, Tang W, Leong RW etal. Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific. Gut 2014; [Epub ahead of print].
43. Prideaux L, Kang S, Wagner J etal. Impact of ethnicity, geography, and disease on the microbiota in health and inflammatory bowel disease. Inflamm. Bowel Dis. 2013; 19: 2906-2918.
44. De CP, Prideaux L, Wagner J etal. Characterization of the gastrointestinal microbiota in health and inflammatory bowel disease. Inflamm. Bowel Dis. 2012; 18: 372-390.
45. Ng SC, Chan FK. Infections and inflammatory bowel disease: challenges in Asia. J. Dig. Dis. 2013; 14: 567-573.